1-9 of 9
Alessia Lamolinara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2609: Vesicular LGALS3BP is a neuroblastoma biomarker and a therapeutic target for combination therapy with antibody-drug conjugate and checkpoint inhibitors

Gianluca Sala, Emily Capone, Ilaria Cela, Giulio Lovato, Alessia Lamolinara, Manuela Iezzi, Cosmo Rossi, Vincenzo De Laurenzi, Rodolfo Ippoliti, Stefano Iacobelli
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2609.
https://doi.org/10.1158/1538-7445.AM2024-2609
Published: 22 March 2024
View articletitled, Abstract 2609: Vesicular LGALS3BP is a neuroblastoma biomarker and a therapeutic target for combination therapy with antibody-drug conjugate and checkpoint inhibitors
Journal Articles

Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism

Rosanna Dattilo, Carla Mottini, Emanuela Camera, Alessia Lamolinara, Noam Auslander, Ginevra Doglioni, Michela Muscolini, Wei Tang, Melanie Planque, Cristiana Ercolani, Simonetta Buglioni, Isabella Manni, Daniela Trisciuoglio, Alessandra Boe, Sveva Grande, Anna Maria Luciani, Manuela Iezzi, Gennaro Ciliberto, Stefan Ambs, Ruggero De Maria, Sarah-Maria Fendt, Eytan Ruppin, Luca Cardone
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (19): 4087–4102.
https://doi.org/10.1158/0008-5472.CAN-19-1184
Published: 02 October 2020
View articletitled, Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
Open the PDF for Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism in another window
Includes: Supplementary data
Journal Articles

Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma

Carla Mottini, Hideo Tomihara, Diego Carrella, Alessia Lamolinara, Manuela Iezzi, Justin K. Huang, Carla A. Amoreo, Simonetta Buglioni, Isabella Manni, Frederick S. Robinson, Rosalba Minelli, Ya'an Kang, Jason B. Fleming, Michael P. Kim, Christopher A. Bristow, Daniela Trisciuoglio, Antonella Iuliano, Donatella Del Bufalo, Diego Di Bernardo, Davide Melisi, Giulio F. Draetta, Gennaro Ciliberto, Alessandro Carugo, Luca Cardone
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (21): 5612–5625.
https://doi.org/10.1158/0008-5472.CAN-19-0187
Published: 01 November 2019
View articletitled, Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
Open the PDF for Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 41: An Antibody Drug Conjugate targeting HER-3 demonstrates promising antitumor efficacy in a wide range of human cancer

Gianluca Sala, Manuela Iezzi, Alessia Lamolinara, Emily Capone, Stefano Iacobelli, Jean-Fred Sauniere, Sara Ponziani, Francesco Giansanti, Rodolfo Ippoliti
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 41.
https://doi.org/10.1158/1538-7445.AM2017-41
Published: 01 July 2017
View articletitled, Abstract 41: An Antibody Drug Conjugate targeting HER-3 demonstrates promising antitumor efficacy in a wide range of human cancer
Journal Articles

Abstract 1200: HER-2 isoform interaction in mammary carcinoma onset and progression

Arianna Palladini, Massimiliano Dall’Ora, Tania Balboni, Giordano Nicoletti, Marianna Ianzano, Roberta Laranga, Lorena Landuzzi, Veronica Giusti, Alessia Lamolinara, Carla De Giovanni, Augusto Amici, Serenella M. Pupa, Manuela Iezzi, Patrizia Nanni, Pier-Luigi Lollini
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1200.
https://doi.org/10.1158/1538-7445.AM2016-1200
Published: 15 July 2016
View articletitled, Abstract 1200: HER-2 isoform interaction in mammary carcinoma onset and progression
Journal Articles

Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies

Sara Sandri, Sara Bobisse, Kelly Moxley, Alessia Lamolinara, Francesco De Sanctis, Federico Boschi, Andrea Sbarbati, Giulio Fracasso, Giovanna Ferrarini, Rudi W. Hendriks, Chiara Cavallini, Maria Teresa Scupoli, Silvia Sartoris, Manuela Iezzi, Michael I. Nishimura, Vincenzo Bronte, Stefano Ugel
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (9): 2540–2551.
https://doi.org/10.1158/0008-5472.CAN-15-2318
Published: 01 May 2016
View articletitled, Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies
Open the PDF for Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies in another window
Includes: Supplementary data
Journal Articles

Abstract 2314: d16HER2 splice variant regulates the activity of HER2-positive breast cancer-initiating cells

Lorenzo Castagnoli, Ada Koschorke, Gaia C. Ghedini, Lorenzo Galvani, Valentina Ciravolo, Cristina Ghirelli, Arianna Palladini, Alessia Lamolinara, Manuela Iezzi, Pier Luigi Lollini, Tiziana Triulzi, Patrizia Nanni, Elda Tagliabue, Serenella M. Pupa
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2314.
https://doi.org/10.1158/1538-7445.AM2015-2314
Published: 01 August 2015
View articletitled, Abstract 2314: d16HER2 splice variant regulates the activity of HER2-positive breast cancer-initiating cells
Journal Articles

Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab

Lorenzo Castagnoli, Manuela Iezzi, Gaia C. Ghedini, Valentina Ciravolo, Giulia Marzano, Alessia Lamolinara, Roberta Zappasodi, Patrizia Gasparini, Manuela Campiglio, Augusto Amici, Claudia Chiodoni, Arianna Palladini, Pier Luigi Lollini, Tiziana Triulzi, Sylvie Menard, Patrizia Nanni, Elda Tagliabue, Serenella M. Pupa
Journal: Cancer Research
Series: Author Choice
Cancer Res (2014) 74 (21): 6248–6259.
https://doi.org/10.1158/0008-5472.CAN-14-0983
Published: 30 October 2014
View articletitled, Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab
Open the PDF for Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab in another window
Includes: Supplementary data
Journal Articles

Abstract 2637: Role of d16HER2 splice variant in HER2-positive breast cancer

Gaia C. Ghedini, Arianna Palladini, Valentina Ciravolo, Lorenzo Castagnoli, Giulia Marzano, Roberta Zappasodi, Guido Santilli, Augusto Amici, Alessia Lamolinara, Manuela Iezzi, Patrizia Nanni, Elda Tagliabue, Serenella M. Pupa
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2637.
https://doi.org/10.1158/1538-7445.AM2014-2637
Published: 01 October 2014
View articletitled, Abstract 2637: Role of d16HER2 splice variant in HER2-positive breast cancer